The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2Seventy Bio Inc | COMMON STOCK | 901384107 | 4,690 | 459,836 | SH | OTR | 459,836 | 0 | 0 | ||
89Bio Inc | COM | 282559103 | 31,983 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
Akero Therapeutics Inc | COM | 00973Y108 | 31,813 | 831,495 | SH | OTR | 831,495 | 0 | 0 | ||
Alaunos Therapeutics Inc | COM | 98973P101 | 945 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
Amicus Therapeutics Inc | COM | 03152W109 | 25,784 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 61,145 | 2,084,000 | SH | OTR | 2,084,000 | 0 | 0 | ||
AnaptysBio Inc | COM | 032724106 | 28,288 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
Apellis Pharmaceuticals Inc | COM | 03753U106 | 103,953 | 1,576,000 | SH | OTR | 1,576,000 | 0 | 0 | ||
Arcus Biosciences Inc | COM | 03969F109 | 26,123 | 1,432,200 | SH | OTR | 1,432,200 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 10,186 | 95,000 | SH | OTR | 95,000 | 0 | 0 | ||
Atreca Inc | CL A COM | 04965G109 | 2,511 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
Avidity Biosciences Inc | COM | 05370A108 | 17,212 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
Axsome Therapeutics Inc | COM | 05464T104 | 24,672 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
BeiGene Ltd | SPONSORED ADR | 07725L102 | 107,765 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
Bellus Health Inc New | COM NEW | 07987C204 | 23,040 | 3,200,000 | SH | OTR | 3,200,000 | 0 | 0 | ||
BioAtla Inc | COM | 09077B104 | 1,839 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
Black Diamond Therapeutics I | COM | 09203E105 | 3,808 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
Cabaletta Bio Inc | COM | 12674W109 | 4,466 | 540,000 | SH | OTR | 540,000 | 0 | 0 | ||
Centessa Pharmaceuticals PLC | SPONSORED ADS | 152309100 | 4,817 | 1,251,137 | SH | OTR | 1,251,137 | 0 | 0 | ||
Cogent Biosciences Inc | COM | 19240Q201 | 5,665 | 525,000 | SH | OTR | 525,000 | 0 | 0 | ||
Cullinan Oncology Inc | COM | 230031106 | 10,988 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | ||
Cytokinetics Inc | COM NEW | 23282W605 | 73,899 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
Day One Biopharmaceuticals I | COM | 23954D109 | 15,910 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
DBV Technologies S A | SPONSORED ADR | 23306J101 | 2,451 | 1,450,000 | SH | OTR | 1,450,000 | 0 | 0 | ||
Disc Medicine Inc | COM | 254604101 | 2,755 | 130,000 | SH | OTR | 130,000 | 0 | 0 | ||
Enliven Therapeutics Inc | COM | 29337E102 | 15,563 | 710,644 | SH | OTR | 710,644 | 0 | 0 | ||
EQRx Inc | COM | 26886C107 | 1,940 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
Exelixis Inc | COM | 30161Q104 | 22,322 | 1,150,000 | SH | OTR | 1,150,000 | 0 | 0 | ||
Fate Therapeutics Inc | COM | 31189P102 | 2,850 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
Gossamer Bio Inc | COM | 38341P102 | 4,205 | 3,336,928 | SH | OTR | 3,336,928 | 0 | 0 | ||
Ideaya Biosciences Inc | COM | 45166A102 | 30,245 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
Iovance Biotherapeutics Inc | COM | 462260100 | 22,638 | 3,705,133 | SH | OTR | 3,705,133 | 0 | 0 | ||
iTeos Therapeutics Inc | COM | 46565G104 | 29,317 | 2,154,058 | SH | OTR | 2,154,058 | 0 | 0 | ||
Iveric Bio Inc | COM | 46583P102 | 20,072 | 825,000 | SH | OTR | 825,000 | 0 | 0 | ||
Kalvista Pharmaceuticals Inc | COM | 483497103 | 12,969 | 1,650,000 | SH | OTR | 1,650,000 | 0 | 0 | ||
Kinnate Biopharma Inc | COM | 49705R105 | 3,188 | 510,000 | SH | OTR | 510,000 | 0 | 0 | ||
MEI Pharma Inc | COM NEW | 55279B202 | 667 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
Mereo Biopharma Group PLC | SPON ADS | 589492107 | 1,591 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
Merus N V | COM | N5749R100 | 34,960 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
Milestone Pharmaceuticals In | COM | 59935V107 | 2,754 | 698,861 | SH | OTR | 698,861 | 0 | 0 | ||
Mirati Therapeutics Inc | COM | 60468T105 | 74,360 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
Morphic Hldg Inc | COM | 61775R105 | 7,528 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
NGM Biopharmaceuticals Inc | COM | 62921N105 | 2,040 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
Nurix Therapeutics Inc | COM | 67080M103 | 10,877 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | ||
Nuvalent Inc | COM | 670703107 | 31,574 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | ||
Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 32 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
Orchestra Biomed Hldgs Inc | COM | 68572M106 | 4,893 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
Oric Pharmaceuticals Inc | COM | 68622P109 | 6,008 | 1,054,000 | SH | OTR | 1,054,000 | 0 | 0 | ||
Panacea Acquisition Corp II | CL A SHS | G6882C106 | 5,110 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
PMV Pharmaceuticals Inc | COM | 69353Y103 | 15,091 | 3,163,795 | SH | OTR | 3,163,795 | 0 | 0 | ||
Point Biopharma Global Inc | COM | 730541109 | 18,175 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
Prelude Therapeutics Inc | COM | 74065P101 | 3,985 | 699,047 | SH | OTR | 699,047 | 0 | 0 | ||
Prometheus Biosciences Inc | COM | 74349U108 | 203,640 | 1,897,500 | SH | OTR | 1,897,500 | 0 | 0 | ||
Protara Therapeutics Inc | COM STK | 74365U107 | 655 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
Prothena Corp PLC | SHS | G72800108 | 14,541 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
Rain Oncology Inc | COM | 75082Q105 | 18,767 | 2,147,212 | SH | OTR | 2,147,212 | 0 | 0 | ||
Rapt Therapeutics Inc | COM | 75382E109 | 5,505 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
Reata Pharmaceuticals Inc | CL A | 75615P103 | 111,832 | 1,230,004 | SH | OTR | 1,230,004 | 0 | 0 | ||
Relay Therapeutics Inc | COM | 75943R102 | 35,726 | 2,169,132 | SH | OTR | 2,169,132 | 0 | 0 | ||
Revolution Medicines Inc | COM | 76155X100 | 101,461 | 4,684,264 | SH | OTR | 4,684,264 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | COM | 77313F106 | 25,113 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
Sage Therapeutics Inc | COM | 78667J108 | 45,904 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
Sarepta Therapeutics Inc | COM | 803607100 | 106,818 | 775,000 | SH | OTR | 775,000 | 0 | 0 | ||
Seagen Inc | COM | 81181C104 | 40,494 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
Selecta Biosciences Inc | COM | 816212104 | 4,565 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
Springworks Therapeutics Inc | COM | 85205L107 | 88,070 | 3,421,541 | SH | OTR | 3,421,541 | 0 | 0 | ||
Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 4 | 66,666 | SH | OTR | 66,666 | 0 | 0 | ||
Tango Therapeutics Inc | COM | 87583X109 | 28,138 | 7,123,642 | SH | OTR | 7,123,642 | 0 | 0 | ||
Theseus Pharmaceuticals Inc | COM | 88369M101 | 3,108 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
Third Harmonic Bio Inc | COM | 88427A107 | 2,350 | 570,417 | SH | OTR | 570,417 | 0 | 0 | ||
Tyra Biosciences Inc | COM | 90240B106 | 103,625 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | ||
Ventyx Biosciences Inc | COM | 92332V107 | 28,475 | 850,000 | SH | OTR | 850,000 | 0 | 0 | ||
Veru Inc | COM | 92536C103 | 403 | 347,300 | SH | OTR | 347,300 | 0 | 0 | ||
Viking Therapeutics Inc | COM | 92686J106 | 33,300 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | COM | 98420N105 | 21,474 | 600,000 | SH | OTR | 600,000 | 0 | 0 |